loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
kpcc in person
.
.
mayo clinic: "migraine: diagnosis & treatment," "monoclonal antibody drugs for cancer: how they work."
., an emerita professor in the department of food science & technology at uc davis.
.
.